News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma
Jan 29, 2025, 08:02

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma

Abdul Rahman Jazieh, Chief Executive Officer at Innovative Healthcare Institute, shared a post on Facebook:

“Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study”

Authors: Aung Naing, Amit Mahipal, Milind Javle, Judy Wang, Todd M. Bauer, David L. Bajor, Anthony D. Elias, Anthony Shields, Elizabeth Davis, Sant Chawla, Howard Safran, John D. Powderly, Gina D’Amato, Christian F. Meyer, Xiongwen Tang, Sheng Yao, Patricia Keegan

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma

Abdul Rahman Jazieh Amit Mahipal Anthony D. Elias Anthony Shields Aung Naing cancer Christian F Meyer David L. Bajor Elizabeth Davis Gina D’Amato Howard Safran John D. Powderly Judy Wang Milind Javle OncoDaily Oncology Patricia Keegan Sant Chawla Sheng Yao Todd M Bauer Xiongwen Tang
Special Coverage
Blog
Jan 29, 2025, 08:02
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma
Blog
Jan 29, 2025, 07:56
Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring
Blog
Jan 29, 2025, 07:53
Krishan Jethwa: Prognostic significance of detectable ctDNA in the NEO-trial
Blog
Jan 29, 2025, 07:52
Kelsey Pan: Encorafenib, cetuximab and nivolumab in patients with BRAF V600E mutated mCRC
Blog
Jan 29, 2025, 07:48
How do copy no. deletions in STK11, KEAP1 and SMARCA4 impact outcomes in NSCLC?
Blog
Jan 29, 2025, 07:46
Krishan Jethwa: Highlighting comparison of OPRA vs AIO-12
Blog
Jan 29, 2025, 07:45
Eric Singhi: Reducing IRRs with IV amivantamab in EGFR+ mNSCLC post osimertinib/chemotherapy
Blog
Jan 29, 2025, 07:43
Pashtoon Kasi: Immunotherapy's Potential in Refractory Patients with Liver Metastases
Blog
Jan 29, 2025, 07:41
Cathy Eng: Role of ctDNA and the impact on decision making in stage II/III colon cancer disease
Blog
Jan 29, 2025, 07:39
Sharlene Gill: Practice-changing ALASCCA ph3 trial
Blog
Jan 29, 2025, 07:38
Mark Lewis: Learning the Power of Saying No
Blog
Jan 29, 2025, 07:37
Bishal Gyawali: Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring